19
Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.
One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.
Regulatory Information RX
With a dosage strength 20MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2018-10-09
Therapeutic Equivalence (TE) Code AB
18
Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.
One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.
Regulatory Information RX
With a dosage strength 10MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2018-10-09
Therapeutic Equivalence (TE) Code AB
17
Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.
One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.
Regulatory Information RX
With a dosage strength 35MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2018-10-09
Therapeutic Equivalence (TE) Code AB
16
Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.
One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.
Regulatory Information RX
With a dosage strength 25MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2018-10-09
Therapeutic Equivalence (TE) Code AB
15
Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.
One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.
Regulatory Information RX
With a dosage strength 15MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2018-10-09
Therapeutic Equivalence (TE) Code AB
14
Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.
One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.
Regulatory Information RX
With a dosage strength 5MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2018-10-09
Therapeutic Equivalence (TE) Code AB
13
Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.
One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.
Regulatory Information RX
With a dosage strength 40MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2018-10-09
Therapeutic Equivalence (TE) Code AB
12
Adare Pharma Solutions, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.
One of their notable products is DEXMETHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 210279.
Regulatory Information RX
With a dosage strength 30MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2018-10-09
Therapeutic Equivalence (TE) Code AB